A456070 logo

ENCell Co., Ltd. Stock Price

KOSDAQ:A456070 Community·₩156.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A456070 Share Price Performance

₩14,280.00
-420.00 (-2.86%)
₩14,280.00
-420.00 (-2.86%)
Price ₩14,280.00

A456070 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
0 Rewards

ENCell Co., Ltd. Key Details

₩5.3b

Revenue

₩7.7b

Cost of Revenue

-₩2.4b

Gross Profit

₩13.7b

Other Expenses

-₩16.1b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-1.47k
-46.03%
-306.30%
23.6%
View Full Analysis

About A456070

Founded
2018
Employees
n/a
CEO
n/a
WebsiteView website
encellinc.com

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease. It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.

Recent A456070 News & Updates

Recent updates

No updates